Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol
An injection of unesterified oestradiol (E2) facilitates receptive behaviour in E2 benzoate (EB)‐primed, ovariectomised female rats when it is administered i.c.v. or systemically. The present study tested the hypothesis that inhibitors of protein kinase A (PKA), protein kinase G (PKG) or the Src/mit...
Gespeichert in:
Veröffentlicht in: | Journal of neuroendocrinology 2019-12, Vol.31 (12), p.e12809-n/a |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 12 |
container_start_page | e12809 |
container_title | Journal of neuroendocrinology |
container_volume | 31 |
creator | Domínguez‐Ordóñez, Raymundo García‐Juárez, Marcos Lima‐Hernández, Francisco J. Gómora‐Arrati, Porfirio Domínguez‐Salazar, Emilio Luna‐Hernández, Ailyn Hoffman, Kurt L. Blaustein, Jeffrey D. Etgen, Anne M. González‐Flores, Oscar |
description | An injection of unesterified oestradiol (E2) facilitates receptive behaviour in E2 benzoate (EB)‐primed, ovariectomised female rats when it is administered i.c.v. or systemically. The present study tested the hypothesis that inhibitors of protein kinase A (PKA), protein kinase G (PKG) or the Src/mitogen‐activated protein kinase (MAPK) complex interfere with E2 facilitation of receptive behaviour. In Experiment 1, lordosis induced by i.c.v. infusion of E2 was significantly reduced by i.c.v. administration of Rp‐cAMPS, a PKA inhibitor, KT5823, a PKG inhibitor, and PP2 and PD98059, Src and MAPK inhibitors, respectively, between 30 and 240 minutes after infusion. In Experiment 2, we determined whether the ventromedial hypothalamus (VMH) is one of the neural sites at which those intracellular pathways participate in lordosis behaviour induced by E2. Administration of each of the four protein kinase inhibitors into the VMH blocked facilitation of lordosis induced by infusion of E2 also into the VMH. These data support the hypothesis that activation of several protein kinase pathways is involved in the facilitation of lordosis by E2 in EB‐primed rats. |
doi_str_mv | 10.1111/jne.12809 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2330478514</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2330478514</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3539-3b8e939050728c8446c84d69ece31f82f653fc64ae262e54cd5ca4dd95f7d903</originalsourceid><addsrcrecordid>eNp1kMtOxCAUhonR6HhZ-AKGxJWLKpTSlqUxXmPUhfuGgUPKyJQRqKYP4vuKjrqTxTkEvnx_8iN0SMkpzedsMcApLVsiNtCMspoXZVvWm2hGBGdFS0W1g3ZjXBBCG87INtphtKGcMDpDH0_BJ7ADfrGDjIDt0Nu5TT7EfDVjBJ13CvIN8rRqdDK4Cfvw9epx6gF___glaCsd7qeVT710cjlGPHdeveDY-5CwkwkGNWEjlXU2yWT9gL3Bzgfto81wtkLMSdp6t4-2jHQRDn72Hnq-uny-uCnuH69vL87vC8U4EwWbtyCYIJw0Zavaqqrz0LUABYyatjQ1Z0bVlYSyLoFXSnMlK60FN40WhO2h47V2FfzrmNO7hR_DkBO7kjFSNS2nVaZO1pQKPsYAplsFu5Rh6ijpvvrvcv_dd_-ZPfoxjvNcyR_5W3gGztbAu3Uw_W_q7h4u18pPVASTlA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2330478514</pqid></control><display><type>article</type><title>Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Domínguez‐Ordóñez, Raymundo ; García‐Juárez, Marcos ; Lima‐Hernández, Francisco J. ; Gómora‐Arrati, Porfirio ; Domínguez‐Salazar, Emilio ; Luna‐Hernández, Ailyn ; Hoffman, Kurt L. ; Blaustein, Jeffrey D. ; Etgen, Anne M. ; González‐Flores, Oscar</creator><creatorcontrib>Domínguez‐Ordóñez, Raymundo ; García‐Juárez, Marcos ; Lima‐Hernández, Francisco J. ; Gómora‐Arrati, Porfirio ; Domínguez‐Salazar, Emilio ; Luna‐Hernández, Ailyn ; Hoffman, Kurt L. ; Blaustein, Jeffrey D. ; Etgen, Anne M. ; González‐Flores, Oscar</creatorcontrib><description>An injection of unesterified oestradiol (E2) facilitates receptive behaviour in E2 benzoate (EB)‐primed, ovariectomised female rats when it is administered i.c.v. or systemically. The present study tested the hypothesis that inhibitors of protein kinase A (PKA), protein kinase G (PKG) or the Src/mitogen‐activated protein kinase (MAPK) complex interfere with E2 facilitation of receptive behaviour. In Experiment 1, lordosis induced by i.c.v. infusion of E2 was significantly reduced by i.c.v. administration of Rp‐cAMPS, a PKA inhibitor, KT5823, a PKG inhibitor, and PP2 and PD98059, Src and MAPK inhibitors, respectively, between 30 and 240 minutes after infusion. In Experiment 2, we determined whether the ventromedial hypothalamus (VMH) is one of the neural sites at which those intracellular pathways participate in lordosis behaviour induced by E2. Administration of each of the four protein kinase inhibitors into the VMH blocked facilitation of lordosis induced by infusion of E2 also into the VMH. These data support the hypothesis that activation of several protein kinase pathways is involved in the facilitation of lordosis by E2 in EB‐primed rats.</description><identifier>ISSN: 0953-8194</identifier><identifier>EISSN: 1365-2826</identifier><identifier>DOI: 10.1111/jne.12809</identifier><identifier>PMID: 31715031</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Animals ; Carbazoles - pharmacology ; Cyclic AMP - analogs & derivatives ; Cyclic AMP - pharmacology ; Estradiol - physiology ; Estrogen Antagonists - pharmacology ; Female ; Flavonoids - pharmacology ; Hypothalamus (ventromedial) ; Infusions, Intraventricular ; Kinases ; Latency ; Lordosis - chemically induced ; Lordosis - physiopathology ; lordosis behaviour ; Male ; MAP kinase ; Microinjections ; mitogen‐activated protein kinase ; oestradiol ; Protein kinase A ; Protein kinase G ; protein kinase inhibitor ; Protein kinase inhibitors ; Protein Kinase Inhibitors - administration & dosage ; Protein Kinase Inhibitors - pharmacology ; Proteins ; Pyrimidines - pharmacology ; Rats ; Src protein ; Src tyrosine kinase ; Thionucleotides - pharmacology ; Ventromedial Hypothalamic Nucleus - drug effects ; Ventromedial Hypothalamic Nucleus - physiology</subject><ispartof>Journal of neuroendocrinology, 2019-12, Vol.31 (12), p.e12809-n/a</ispartof><rights>2019 British Society for Neuroendocrinology</rights><rights>2019 British Society for Neuroendocrinology.</rights><rights>Copyright © 2019 British Society for Neuroendocrinology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3539-3b8e939050728c8446c84d69ece31f82f653fc64ae262e54cd5ca4dd95f7d903</citedby><cites>FETCH-LOGICAL-c3539-3b8e939050728c8446c84d69ece31f82f653fc64ae262e54cd5ca4dd95f7d903</cites><orcidid>0000-0003-2145-0863 ; 0000-0003-1388-7088</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjne.12809$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjne.12809$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31715031$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Domínguez‐Ordóñez, Raymundo</creatorcontrib><creatorcontrib>García‐Juárez, Marcos</creatorcontrib><creatorcontrib>Lima‐Hernández, Francisco J.</creatorcontrib><creatorcontrib>Gómora‐Arrati, Porfirio</creatorcontrib><creatorcontrib>Domínguez‐Salazar, Emilio</creatorcontrib><creatorcontrib>Luna‐Hernández, Ailyn</creatorcontrib><creatorcontrib>Hoffman, Kurt L.</creatorcontrib><creatorcontrib>Blaustein, Jeffrey D.</creatorcontrib><creatorcontrib>Etgen, Anne M.</creatorcontrib><creatorcontrib>González‐Flores, Oscar</creatorcontrib><title>Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol</title><title>Journal of neuroendocrinology</title><addtitle>J Neuroendocrinol</addtitle><description>An injection of unesterified oestradiol (E2) facilitates receptive behaviour in E2 benzoate (EB)‐primed, ovariectomised female rats when it is administered i.c.v. or systemically. The present study tested the hypothesis that inhibitors of protein kinase A (PKA), protein kinase G (PKG) or the Src/mitogen‐activated protein kinase (MAPK) complex interfere with E2 facilitation of receptive behaviour. In Experiment 1, lordosis induced by i.c.v. infusion of E2 was significantly reduced by i.c.v. administration of Rp‐cAMPS, a PKA inhibitor, KT5823, a PKG inhibitor, and PP2 and PD98059, Src and MAPK inhibitors, respectively, between 30 and 240 minutes after infusion. In Experiment 2, we determined whether the ventromedial hypothalamus (VMH) is one of the neural sites at which those intracellular pathways participate in lordosis behaviour induced by E2. Administration of each of the four protein kinase inhibitors into the VMH blocked facilitation of lordosis induced by infusion of E2 also into the VMH. These data support the hypothesis that activation of several protein kinase pathways is involved in the facilitation of lordosis by E2 in EB‐primed rats.</description><subject>Animals</subject><subject>Carbazoles - pharmacology</subject><subject>Cyclic AMP - analogs & derivatives</subject><subject>Cyclic AMP - pharmacology</subject><subject>Estradiol - physiology</subject><subject>Estrogen Antagonists - pharmacology</subject><subject>Female</subject><subject>Flavonoids - pharmacology</subject><subject>Hypothalamus (ventromedial)</subject><subject>Infusions, Intraventricular</subject><subject>Kinases</subject><subject>Latency</subject><subject>Lordosis - chemically induced</subject><subject>Lordosis - physiopathology</subject><subject>lordosis behaviour</subject><subject>Male</subject><subject>MAP kinase</subject><subject>Microinjections</subject><subject>mitogen‐activated protein kinase</subject><subject>oestradiol</subject><subject>Protein kinase A</subject><subject>Protein kinase G</subject><subject>protein kinase inhibitor</subject><subject>Protein kinase inhibitors</subject><subject>Protein Kinase Inhibitors - administration & dosage</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Proteins</subject><subject>Pyrimidines - pharmacology</subject><subject>Rats</subject><subject>Src protein</subject><subject>Src tyrosine kinase</subject><subject>Thionucleotides - pharmacology</subject><subject>Ventromedial Hypothalamic Nucleus - drug effects</subject><subject>Ventromedial Hypothalamic Nucleus - physiology</subject><issn>0953-8194</issn><issn>1365-2826</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtOxCAUhonR6HhZ-AKGxJWLKpTSlqUxXmPUhfuGgUPKyJQRqKYP4vuKjrqTxTkEvnx_8iN0SMkpzedsMcApLVsiNtCMspoXZVvWm2hGBGdFS0W1g3ZjXBBCG87INtphtKGcMDpDH0_BJ7ADfrGDjIDt0Nu5TT7EfDVjBJ13CvIN8rRqdDK4Cfvw9epx6gF___glaCsd7qeVT710cjlGPHdeveDY-5CwkwkGNWEjlXU2yWT9gL3Bzgfto81wtkLMSdp6t4-2jHQRDn72Hnq-uny-uCnuH69vL87vC8U4EwWbtyCYIJw0Zavaqqrz0LUABYyatjQ1Z0bVlYSyLoFXSnMlK60FN40WhO2h47V2FfzrmNO7hR_DkBO7kjFSNS2nVaZO1pQKPsYAplsFu5Rh6ijpvvrvcv_dd_-ZPfoxjvNcyR_5W3gGztbAu3Uw_W_q7h4u18pPVASTlA</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Domínguez‐Ordóñez, Raymundo</creator><creator>García‐Juárez, Marcos</creator><creator>Lima‐Hernández, Francisco J.</creator><creator>Gómora‐Arrati, Porfirio</creator><creator>Domínguez‐Salazar, Emilio</creator><creator>Luna‐Hernández, Ailyn</creator><creator>Hoffman, Kurt L.</creator><creator>Blaustein, Jeffrey D.</creator><creator>Etgen, Anne M.</creator><creator>González‐Flores, Oscar</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><orcidid>https://orcid.org/0000-0003-2145-0863</orcidid><orcidid>https://orcid.org/0000-0003-1388-7088</orcidid></search><sort><creationdate>201912</creationdate><title>Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol</title><author>Domínguez‐Ordóñez, Raymundo ; García‐Juárez, Marcos ; Lima‐Hernández, Francisco J. ; Gómora‐Arrati, Porfirio ; Domínguez‐Salazar, Emilio ; Luna‐Hernández, Ailyn ; Hoffman, Kurt L. ; Blaustein, Jeffrey D. ; Etgen, Anne M. ; González‐Flores, Oscar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3539-3b8e939050728c8446c84d69ece31f82f653fc64ae262e54cd5ca4dd95f7d903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Carbazoles - pharmacology</topic><topic>Cyclic AMP - analogs & derivatives</topic><topic>Cyclic AMP - pharmacology</topic><topic>Estradiol - physiology</topic><topic>Estrogen Antagonists - pharmacology</topic><topic>Female</topic><topic>Flavonoids - pharmacology</topic><topic>Hypothalamus (ventromedial)</topic><topic>Infusions, Intraventricular</topic><topic>Kinases</topic><topic>Latency</topic><topic>Lordosis - chemically induced</topic><topic>Lordosis - physiopathology</topic><topic>lordosis behaviour</topic><topic>Male</topic><topic>MAP kinase</topic><topic>Microinjections</topic><topic>mitogen‐activated protein kinase</topic><topic>oestradiol</topic><topic>Protein kinase A</topic><topic>Protein kinase G</topic><topic>protein kinase inhibitor</topic><topic>Protein kinase inhibitors</topic><topic>Protein Kinase Inhibitors - administration & dosage</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Proteins</topic><topic>Pyrimidines - pharmacology</topic><topic>Rats</topic><topic>Src protein</topic><topic>Src tyrosine kinase</topic><topic>Thionucleotides - pharmacology</topic><topic>Ventromedial Hypothalamic Nucleus - drug effects</topic><topic>Ventromedial Hypothalamic Nucleus - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Domínguez‐Ordóñez, Raymundo</creatorcontrib><creatorcontrib>García‐Juárez, Marcos</creatorcontrib><creatorcontrib>Lima‐Hernández, Francisco J.</creatorcontrib><creatorcontrib>Gómora‐Arrati, Porfirio</creatorcontrib><creatorcontrib>Domínguez‐Salazar, Emilio</creatorcontrib><creatorcontrib>Luna‐Hernández, Ailyn</creatorcontrib><creatorcontrib>Hoffman, Kurt L.</creatorcontrib><creatorcontrib>Blaustein, Jeffrey D.</creatorcontrib><creatorcontrib>Etgen, Anne M.</creatorcontrib><creatorcontrib>González‐Flores, Oscar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of neuroendocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Domínguez‐Ordóñez, Raymundo</au><au>García‐Juárez, Marcos</au><au>Lima‐Hernández, Francisco J.</au><au>Gómora‐Arrati, Porfirio</au><au>Domínguez‐Salazar, Emilio</au><au>Luna‐Hernández, Ailyn</au><au>Hoffman, Kurt L.</au><au>Blaustein, Jeffrey D.</au><au>Etgen, Anne M.</au><au>González‐Flores, Oscar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol</atitle><jtitle>Journal of neuroendocrinology</jtitle><addtitle>J Neuroendocrinol</addtitle><date>2019-12</date><risdate>2019</risdate><volume>31</volume><issue>12</issue><spage>e12809</spage><epage>n/a</epage><pages>e12809-n/a</pages><issn>0953-8194</issn><eissn>1365-2826</eissn><abstract>An injection of unesterified oestradiol (E2) facilitates receptive behaviour in E2 benzoate (EB)‐primed, ovariectomised female rats when it is administered i.c.v. or systemically. The present study tested the hypothesis that inhibitors of protein kinase A (PKA), protein kinase G (PKG) or the Src/mitogen‐activated protein kinase (MAPK) complex interfere with E2 facilitation of receptive behaviour. In Experiment 1, lordosis induced by i.c.v. infusion of E2 was significantly reduced by i.c.v. administration of Rp‐cAMPS, a PKA inhibitor, KT5823, a PKG inhibitor, and PP2 and PD98059, Src and MAPK inhibitors, respectively, between 30 and 240 minutes after infusion. In Experiment 2, we determined whether the ventromedial hypothalamus (VMH) is one of the neural sites at which those intracellular pathways participate in lordosis behaviour induced by E2. Administration of each of the four protein kinase inhibitors into the VMH blocked facilitation of lordosis induced by infusion of E2 also into the VMH. These data support the hypothesis that activation of several protein kinase pathways is involved in the facilitation of lordosis by E2 in EB‐primed rats.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31715031</pmid><doi>10.1111/jne.12809</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-2145-0863</orcidid><orcidid>https://orcid.org/0000-0003-1388-7088</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0953-8194 |
ispartof | Journal of neuroendocrinology, 2019-12, Vol.31 (12), p.e12809-n/a |
issn | 0953-8194 1365-2826 |
language | eng |
recordid | cdi_proquest_journals_2330478514 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Animals Carbazoles - pharmacology Cyclic AMP - analogs & derivatives Cyclic AMP - pharmacology Estradiol - physiology Estrogen Antagonists - pharmacology Female Flavonoids - pharmacology Hypothalamus (ventromedial) Infusions, Intraventricular Kinases Latency Lordosis - chemically induced Lordosis - physiopathology lordosis behaviour Male MAP kinase Microinjections mitogen‐activated protein kinase oestradiol Protein kinase A Protein kinase G protein kinase inhibitor Protein kinase inhibitors Protein Kinase Inhibitors - administration & dosage Protein Kinase Inhibitors - pharmacology Proteins Pyrimidines - pharmacology Rats Src protein Src tyrosine kinase Thionucleotides - pharmacology Ventromedial Hypothalamic Nucleus - drug effects Ventromedial Hypothalamic Nucleus - physiology |
title | Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A35%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protein%20kinase%20inhibitors%20infused%20intraventricularly%20or%20into%20the%20ventromedial%20hypothalamus%20block%20short%20latency%20facilitation%20of%20lordosis%20by%20oestradiol&rft.jtitle=Journal%20of%20neuroendocrinology&rft.au=Dom%C3%ADnguez%E2%80%90Ord%C3%B3%C3%B1ez,%20Raymundo&rft.date=2019-12&rft.volume=31&rft.issue=12&rft.spage=e12809&rft.epage=n/a&rft.pages=e12809-n/a&rft.issn=0953-8194&rft.eissn=1365-2826&rft_id=info:doi/10.1111/jne.12809&rft_dat=%3Cproquest_cross%3E2330478514%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2330478514&rft_id=info:pmid/31715031&rfr_iscdi=true |